Sökresultat

Role of serotonin neurons in the induction of levodopa and graftinduced dyskinesias in Parkinson's disease Role of Serotonin Neurons in the Induction of Levodopa- and Graft-Induced Dyskinesias in Parkinson’s Disease Manolo Carta, PhD,1,2 Thomas Carlsson, PhD,1,2 Ana Muñoz, PhD,1 Deniz Kirik, MD, PhD,2 and Anders Björklund, MD, PhD1* 1Neurobiology Unit, Wallenberg Neuroscience Center, Department

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/carta_et_al_mov_disord_2010.pdf - 2025-12-31

Microsoft Word - CV for web site March 2020.doc 1 CURRICULUM VITAE FOR ANDERS BJÖRKLUND Born on July 11, 1945 in Söderhamn, Sweden. Current position: Senior Professor of Histology, Wallenberg Neuroscence Center, Lund University, Sweden Web site: www.wnc.se Education: 1964-1967 Medical school, Lund 1966-1969 Doctor of Medicine (Medical Sciences), PhD in histology 1970 Docent of histology at the Uni

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/cv_march_2020.pdf - 2025-12-31

Microsoft Word - My most cited papers.docx 1 Anders Björklund Senior professor of neuroscience, Lund University, Sweden My most cited papers (original articles) based on data obtained in September 2020 from my author page at Google Scholar https://scholar.google.com/citations?user=W8CXjsMAAAAJ&hl=en&oi=ao My 5 most cited original articles related to dopamine cell replacement in Parkinson´s disease

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/most_cited_papers_0.pdf - 2025-12-31

NURR1 in Parkinson disease—from pathogenesis to therapeutic potential NATURE REVIEWS | NEUROLOGY ADVANCE ONLINE PUBLICATION | 1 Wallenberg Neuroscience Centre, Department of Experimental Medical Sciences, Lund University, BMC A11, Lund 22184, Sweden (M. Decressac, A. Björklund). Ludwig Institute for Cancer Research, Karolinska Institute, S‑171 77 Stockholm, Sweden (N. Volakakis, T. Perlmann). Corr

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/nature_rev._neurol._2013.pdf - 2025-12-31

α-Synuclein induced toxicity in brain stem serotonin neurons mediated by an AAV vector driven by the tryptophan hydroxylase promoter 1Scientific RepoRts | 6:26285 | DOI: 10.1038/srep26285 www.nature.com/scientificreports α-Synuclein induced toxicity in brain stem serotonin neurons mediated by an AAV vector driven by the tryptophan hydroxylase promoter Oi Wan Wan1,*, Eunju Shin1,*,†, Bengt Mattsson

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/oiwanwan_et_al_2016.pdf - 2025-12-31

Transcriptome analysis reveals transmembrane targets on transplantable midbrain dopamine progenitors Chris R. Byea, Marie E. Jönssonb, Anders Björklundb,1, Clare L. Parisha, and Lachlan H. Thompsona,1 aFlorey Institute for Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia 3010; and bWallenberg Neuroscience Centre, Department of Experimental Medical Science

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/pnas-2015-bye.pdf - 2025-12-31

Microsoft Word - Annotated publ list April 2020.docx 1 Anders Björklund Professor, Wallenberg Neuroscience Center, Lund University, Lund, Sweden Annotated list of publications My complete list of publications contains about 675 papers, with h-index: 146 (Scopus) 165 (Google Scholar); total citations: 64134 (Scopus) 83260 (Google Scholar), as of April 2020, using “Bjorklund A” and “Lund” as search

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/publ_list_april_2020.pdf - 2025-12-31

Faustini_et_al-2018-Acta_Neuropathologica.pdf Vol.:(0123456789)1 3 Acta Neuropathologica https://doi.org/10.1007/s00401-018-1892-1 ORIGINAL PAPER Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease Gaia Faustini1 · Francesca Longhena1 · Tatiana Varanita2 · Luigi Bubacco2 · Marina Pizzi1 · Cristina

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/publication_in_acta_neuropathol.pdf - 2025-12-31

Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson’s disease RESEARCH Open Access Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson’s disease Anna Tamburrino1, Madeline J. Churchill2, Oi W. Wan3, Yolanda Colino-Sanguino3, Rossana Ippolito1, Sofie Bergstrand1, Daniel A. Wolf3, Niculin J. Herz4,

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/publication_in_acta_neuropathol_commun.pdf - 2025-12-31

awr149 1..10 BRAIN A JOURNAL OF NEUROLOGY GDNF fails to exert neuroprotection in a rat a-synuclein model of Parkinson’s disease Mickael Decressac,1 Ayse Ulusoy,2,* Bengt Mattsson,1 Biljana Georgievska,1,† Marina Romero-Ramos,2,z Deniz Kirik2 and Anders Björklund1 1 Wallenberg Neuroscience Centre, Sölvegatan 17, 221 84 Lund, Sweden 2 Department of Experimental Medical Sciences, Brain Repair and I

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/publication_in_brain_0.pdf - 2025-12-31

OP-BRAI140413 1..11 Eltoprazine counteracts L-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study Per Svenningsson,1 Carl Rosenblad,2 Karolina af Edholm Arvidsson,1 Klas Wictorin,2 Charlotte Keywood,3 Bavani Shankar,4 David A Lowe,4 Anders Björklund5 and Håkan Widner2 See Bezard and Carta for a scientific commentary on this article (doi:10.1093/brain/awu407). In advanced stages

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/publication_in_brain_a_journal_of_neurology.pdf - 2025-12-31

From Skin to Brain: A Parkinson’...s Own Cells | Elsevier Enhanced Reader 16/08/2020 From Skin to Brain: A Parkinson’s Disease Patient Transplanted with His Own Cells | Elsevier Enhanced Reader https://reader.elsevier.com/reader/sd/pii/S1934590920302757?token=18E0986632EFE43FDEBD61C1E1A53BA2E08480D5DA407F43F9E90D4FF675CCD08… 1/3 16/08/2020 From Skin to Brain: A Parkinson’s Dis

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/publication_in_cellstemcell.pdf - 2025-12-31

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/publication_in_exp_neurol.pdf - 2025-12-31

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/publication_in_experimental_neurology.pdf - 2025-12-31

Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease Experimental Neurology xxx (2012) xxx–xxx YEXNR-11083; No. of pages: 10; 4C: 4, 5, 6, 9 Contents lists available at SciVerse ScienceDirect Experimental Neurology j ourna l homepage: www.e lsev ie r .com/ locate /yexnr Comparison of the behavioural and histological characte

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/publication_in_experimental_neurology_1.pdf - 2025-12-31

fncel-14-00146.pdf REVIEW published: 29 May 2020 doi: 10.3389/fncel.2020.00146 Edited by: Sofia Grade, Institute of Molecular Biotechnology (OeAW), Austria Reviewed by: Daniel Tornero, University of Barcelona, Spain Afsaneh Gaillard, University of Poitiers, France *Correspondence: Anders Björklund anders.bjorklund@med.lu.se Specialty section: This article was submitted to Cellular Neuropathology,

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/publication_in_frontiers_0.pdf - 2025-12-31

Journal of Parkinson’s Disease 9 (2019) 17–29 DOI 10.3233/JPD-181525 IOS Press 17 Review The Amphetamine Induced Rotation Test: A Re-Assessment of Its Use as a Tool to Monitor Motor Impairment and Functional Recovery in Rodent Models of Parkinson’s Disease Anders Björklunda,∗ and Stephen B. Dunnettb a Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund University, Swe

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/publication_in_journal_of_parkinsons_disease.pdf - 2025-12-31

U nc or re ct ed A ut ho r P ro of Journal of Parkinson’s Disease xx (20xx) x–xx DOI 10.3233/JPD-202200 IOS Press 1 Review1 Animal Models of Parkinson’s Disease: Are They Useful or Not? 2 3 Roger A. Barkera,∗ and Anders Björklundb,∗ 4 aDepartment of Clinical Neuroscience and WT-MRC Cambridge Stem Cell Institute, Forvie Site, Cambridge, UK 5 6 bDepartment of Experimental Medical Science, Wallenber

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/publication_in_journal_of_parkinsons_disease_3.pdf - 2025-12-31

Journal of Parkinson’s Disease 10 (2020) 1503–1514 DOI 10.3233/JPD-202061 IOS Press 1503 Research Report BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia Simona Scheggia,1, Francesca Rossib,1, Sara Corsib, Silvia Fannib, Elisabetta Troncib, Ludovica Congiub, Romina Vargiub, Carla Gambaranaa, Ana Muñozc, Roberto Sta

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/publication_in_journal_of_parkinsons_disease_5.pdf - 2025-12-31

JW-MDS#120476 96..109 Trophic Factor Gene Therapy for Parkinson’s Disease Jeffrey H. Kordower, PhD,1* and Anders Bjorklund, MD, PhD2 1Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA 2Wallenberg Neuroscience Center, Lund University, Sweden ABSTRACT: Parkinson’s disease (PD) is a chronic and progressive neurodegenerative movement disorder for which there i

https://www.neurobiology.lu.se/sites/neurobiology.lu.se/files/publication_in_mov_disord_0.pdf - 2025-12-31